1Department of Oncology, Laboratory of Angiogenesis and Vascular Metabolism, Katholieke Universiteit Leuven (KU Leuven), Leuven, Belgium;
2Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, Vlaams Instituut voor Biotechnologie (VIB), Leuven, Belgium;
3State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China;
4Lars Bolund Institute of Regenerative Medicine, Beijing Genomics Institute (BGI)-Qingdao, BGI-Shenzhen, Qingdao, China;
5Department of Biomedicine, Aarhus University, Aarhus, Denmark;
6Division of Nephrology, Department of Internal Medicine, The Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands;
7China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China; and
8Qingdao-Europe Advanced Institute for Life Sciences, Beijing Genomics Institute (BGI)-Qingdao, Qingdao, China
S.J.D., E.M., and M.B. contributed equally to this work.
Present address: Dr. Tobias K. Karakach, University of Manitoba, Department of Pediatrics and Child Health, Winnipeg, MB, Canada.
Correspondence: Prof. Peter Carmeliet, Department of Oncology, Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), Vlaams Instituut voor Biotechnologie (VIB), Herestraat 49 B912, 3000 Leuven, Vlaanderen, Belgium, or Prof. Yonglun Luo, Department of biomedicine, Aarhus University, Høegh-Guldbergs Gade 10, building 1116-152, 8000 Aarhus C, Denmark. Email: [email protected] or [email protected]